Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study

Ruane, P; Strasser, SI; Gane, EJ; Hyland, RH; Shao, J; Dyory-Sobol, H; Tran, T; Stamm, LM; Brainard, DM; Nyberg, L; Shafran, S

Ruane, P (reprint author), Ruane Med & Liver Hlth Inst, Los Angeles, CA 90036 USA.

JOURNAL OF VIRAL HEPATITIS, 2019; 26 (6): 770